For Patients
Find essential information here about ovarian cancer prevention, risk factors, and steps to take if you’ve been newly diagnosed, in treatment or navigating life beyond.
The Clearity Foundation Has Joined OCRA
Together, we’re expanding support, education, and resources for the gynecologic cancer community.
Strengthening Support Through Partnership
Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that The Clearity Foundation has combined with OCRA. This important development brings together two of the most respected organizations in the ovarian cancer field, combining OCRA’s leading research, advocacy, and patient support programs with Clearity’s focus on scientific education and support for women and families facing an ovarian cancer diagnosis.
Please explore the resources below to learn more about the expanded support and tools now available.
Support & Resources
OCRA is here for you and your family to answer questions or connect you with resources to help you and offer support.
Research
OCRA has awarded more than 400 grants and invested $140 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.
Center for Public Policy
OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community, having helped secure $3.8 billion in federal research and education funding since inception..
Get Involved
Help us get one step closer to a cure. There are so many ways to lend a hand and improve the lives of patients and families impacted by ovarian and all gynecologic cancers.
About
OCRA is the leading organization in the world fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.
Related Topics
The Overview: July 2026
SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community. The … Continued
Navigating Platinum-Resistant Ovarian Cancer: Everyday Health Shares Coping Strategies and OCRA Resources
In an article published by Everyday Health, “Coping With the Emotional Challenges of Platinum-Resistant Ovarian Cancer” (June 10, 2026), Ovarian Cancer Research Alliance (OCRA) community member Amanda Widro shares her experience navigating a platinum-resistant ovarian cancer diagnosis. Ovarian cancer is considered platinum-resistant when it recurs within six months of finishing platinum-based chemotherapy. Widro, who was … Continued
OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research
Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued